Medicus Pharma has announced the completion of patient enrollment for its phase 2 SKNJCT-003 trial, evaluating the safety and ...
Such public attacks might have derailed a less politically tested politician, but Zeldin has been around the block. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results